Blog
From AI novice and skeptic… to AI novice
From AI sceptic to cautious adopter, this blog cuts through the hype to explore where AI genuinely helps regulatory professionals—and where human judgement remains non‑negotiable.
>200 companies
We have advised, worked with and supported dozens of funds and biotechs.
>500 million plus
Our input is benefitting patient populations worldwide.
>25 billion USD
Our repeat and long-term clients have realised significant value gains since we became involved in their programmes.